The feature recognizes Dr. Kim’s collaborative work with partners in Kenya to develop a non-invasive, smartphone-based method to detect anemia by analyzing images of the inner eyelid. This technology eliminates the need for blood draws, specialized equipment, and trained personnel—making anemia detection more accessible in low-resource settings.

What began as a proof-of-concept study supported by an initial Fogarty investment has grown into a U.S.-based start-up with wide-reaching applications. The technology platform now extends to diagnosing sickle cell disease, malaria, and pre-eclampsia, with new funding supporting further global and U.S. deployment.

This recognition by the Fogarty International Center underscores the global impact of Dr. Kim’s translational research and the power of cross-border collaborations to address critical health challenges.

Read the full NIH highlight here.